MRK’s 3Q12 sales in China increased 19% YoY: http://www.bloomberg.com/news/2012-10-26/merck-profit-beats-analyst-estimates-on-sales-of-diabetes-drugs.html All told, 20% of 3Q12 revenue came from emerging markets.